| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/02/2011 | US7989676 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 08/02/2011 | US7989616 High-phosphate starch |
| 08/02/2011 | US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/02/2011 | US7989595 Compositions and methods for the diagnosis and treatment of tumor |
| 08/02/2011 | US7989591 Protein lattice |
| 08/02/2011 | US7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 08/02/2011 | US7989205 Cell culture media, kits and methods of use |
| 08/02/2011 | US7989204 Hepatocyte lineage cells |
| 08/02/2011 | US7989203 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
| 08/02/2011 | US7989201 Ret finger protein 2 (RFP2) promoter |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7989181 Methods and compositions for producing recombinant proteins using a gene for TRNA |
| 08/02/2011 | US7989001 Method of separating tumor cells with and without lymphotropic metastatic potential in a human carcinoma |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988964 NOGO-a neutralising immunoglobulin for treatment of neurological diseases |
| 08/02/2011 | US7988963 Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responses |
| 08/02/2011 | US7988962 Use of polysulphated alginate in cellular matrices |
| 08/02/2011 | US7988959 Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a |
| 08/02/2011 | US7988951 Method for inducing selectively suppressed immune response to transplanted tissue or cells |
| 08/02/2011 | CA2475395C Anti-human tenascin monoclonal antibody |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2412650C Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 08/02/2011 | CA2349038C Methods of alleviating cancer symptoms |
| 08/02/2011 | CA2332655C Scce modified transgenic mammals and their use as models of human diseases |
| 08/02/2011 | CA2323757C Antibody variants and fragments thereof |
| 08/02/2011 | CA2307640C Multiply-substituted protease variants |
| 08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
| 07/29/2011 | WO2010085694A2 Watercraft lift system |
| 07/28/2011 | WO2011091420A2 Osteogenic cell delivery matrix |
| 07/28/2011 | WO2011091350A2 Methods & compositions for improving protein production |
| 07/28/2011 | WO2011091319A2 Dendritic cell vaccines |
| 07/28/2011 | WO2011091048A1 Direct conversion of cells to cells of other lineages |
| 07/28/2011 | WO2011090684A2 Methods for developing endothelial cells from pluripotent cells and endothelial cells derived |
| 07/28/2011 | WO2011090297A2 Human adult stem cell for expressing anti-mdm2, and use thereof |
| 07/28/2011 | WO2011090221A1 Method for improving induced pluripotent stem cell generation efficiency |
| 07/28/2011 | WO2011090159A1 Probe reagent for measurement of protein decomposition activity |
| 07/28/2011 | WO2011090091A1 Method for determination whether or not cell population is suitable for foreign gene transfer for the purpose of preparation of adipocytes for gene therapy application |
| 07/28/2011 | WO2011090068A1 Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass |
| 07/28/2011 | WO2011090054A1 Nadh oxidase mutant having improved stability and use thereof |
| 07/28/2011 | WO2011089299A1 Methods and compositions for identifying embryotoxic compounds |
| 07/28/2011 | WO2011089271A1 An inducible baculovirus system in insect cells |
| 07/28/2011 | WO2011089261A1 Use of hydrogels on the basis of guluronic acid- and/or mannuronic acid-containing polysaccharides for treating damage to the nervous system, promoting nerve growth, treating neurodegenerative diseases and cultivating neurons |
| 07/28/2011 | WO2011060342A3 Cardiac differentiation of human pluripotent stem cells under defined conditions using matrix overlay methods |
| 07/28/2011 | WO2011059920A3 Methods of generating neural stem cells |
| 07/28/2011 | WO2011059547A3 Cryopreservation of cells and subcellular fractions |
| 07/28/2011 | WO2011038133A3 Umbilical cord lining stem cells and methods and material for isolating and culturing same |
| 07/28/2011 | WO2011022413A3 Reprogramming a cell by activation of the endogenous transcription factor network |
| 07/28/2011 | WO2011011660A3 Drain down and re-feed of microcarrier bioreactor |
| 07/28/2011 | WO2011005580A3 Adult animals generated from induced pluripotent cells |
| 07/28/2011 | US20110185454 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 07/28/2011 | US20110185452 Compositions and methods for improving plants |
| 07/28/2011 | US20110185450 Plant 1-deoxy-d-xylulose 5-phosphate reductoisomerase |
| 07/28/2011 | US20110185449 Modified Xylan Production |
| 07/28/2011 | US20110185444 Polynucleotide and polypeptide sequences associated with herbicide tolerance |
| 07/28/2011 | US20110185439 G protein coupled receptors and uses thereof |
| 07/28/2011 | US20110184381 Repair of defects or lesions in cartilage and bone using a chondro-regulative matrix |
| 07/28/2011 | US20110184154 Cell broth clarification and host cell protein removal |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184052 Arginase ii: a target for the prevention and treatment of atherosclerosis |
| 07/28/2011 | US20110184050 Methods and means for treating dna repeat instability associated genetic disorders |
| 07/28/2011 | US20110184047 Rnai modulation of scap and therapeutic uses thereof |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184043 Inhibition of angiogenesis |
| 07/28/2011 | US20110184041 PTHrP, ITS ISOFORMS AND ANTAGONIST THERETO IN THE DIAGNOSIS AND TREATMENT OF DISEASE |
| 07/28/2011 | US20110184028 Derivatives of pyridoxine for inhibiting hiv integrase |
| 07/28/2011 | US20110184027 Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification |
| 07/28/2011 | US20110184019 Long chain N-Alkyl compounds and oxa-derivatives thereof |
| 07/28/2011 | US20110183948 Treatment of fibrotic conditions using hedgehog inhibitors |
| 07/28/2011 | US20110183934 Methods and compositions to improve germ cell and embryo survival and function |
| 07/28/2011 | US20110183918 Method of Treating Leukemia Using Rcie Prolamin |
| 07/28/2011 | US20110183917 P53 Activator Peptides |
| 07/28/2011 | US20110183916 Apo-2 Ligand |
| 07/28/2011 | US20110183915 Small Molecule Cancer Treatments that cause Necrosis in Cancer Cells but do not Affect Normal Cells |
| 07/28/2011 | US20110183912 Agent for promoting neuronal differentiation and method therefor |
| 07/28/2011 | US20110183910 Biglycan and related therapeutics and methods of use |
| 07/28/2011 | US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |
| 07/28/2011 | US20110183866 Compositions and methods for treating and diagnosing cancer |
| 07/28/2011 | US20110183865 Lipoxygenase |
| 07/28/2011 | US20110183419 Silica sol material for producing bilogically degradable and/or resorbable silica gel materials, the production and use thereof |
| 07/28/2011 | US20110183418 Peptide-Polymer Cell Culture Articles and Methods of Making |
| 07/28/2011 | US20110183416 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 07/28/2011 | US20110183415 Derivation of embryonic stem cells and embryo-derived cells |
| 07/28/2011 | US20110183414 Expansion Medium for CD34-Negative Stem Cells |
| 07/28/2011 | US20110183413 Biologically active C-terminal arginine-containing peptides |
| 07/28/2011 | US20110183377 Methods, systems and reagents for improved immunodetection |
| 07/28/2011 | US20110183376 Novel anti-igf-ir antibodies and uses thereof |
| 07/28/2011 | US20110183375 Metal binding compounds and their use in cell culture medium compositions |
| 07/28/2011 | US20110183367 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 07/28/2011 | US20110183360 Antibodies to clostridium difficile spores and uses thereof |
| 07/28/2011 | US20110183329 Protein phosphatase-1 inhibitor-1 polymorphism and methods of use |
| 07/28/2011 | US20110183324 Tumor suppressor gene p33ing2 |
| 07/28/2011 | US20110183312 Microfluidic chip for accurately controllable cell culture |
| 07/28/2011 | US20110183014 Product containing extract from zanthoxylum avicennae (lam.) dc., and preparation process and use thereof |
| 07/28/2011 | US20110183001 Compositions and methods for implantation of adipose tissue and adipose tissue products |
| 07/28/2011 | US20110182996 Surface modified nanoparticles, methods of their preparation, and uses thereof for gene and drug delivery |
| 07/28/2011 | US20110182983 Human immortalised neural precursor cell line |
| 07/28/2011 | US20110182979 In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation |
| 07/28/2011 | US20110182978 Activated nitric oxide donors and methods of making and using thereof |